BACKGROUND: The authors evaluated outcomes and treatment costs of ster
eotactic core needle biopsy (SCNB) and ultrasound core needle biopsy (
UCNB), and needle localization biopsy (NLB) in managing patients with
mammographic abnormalities presenting to the surgeon. METHODS: Data fo
r all patients with mammographic lesions who underwent SCNB or UCNB si
nce their introduction at this institution were prospectively collecte
d over 17 months. Mean inclusive costs of the three procedures were ac
cumulated and compared. RESULTS: Stereotactic core needle biopsy was p
erformed for 342 lesions in 319 women, for a malignancy rate of 19%; U
CNB was performed for 157 lesions in 144 patients, yielding a malignan
cy rate of 17%. With a mean follow-up of 13.5 months, 1 patient with i
n situ carcinoma was diagnosed late. Absolute cost savings for the per
iod studied was $721,963. CONCLUSIONS: Minimally invasive breast biops
y procedures can safely and reliably be performed by surgeons in clini
cal practice with increased patient convenience and decreased costs. (
C) 1997 by Excerpta Medica, Inc.